-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Enanta Pharmaceuticals Inc quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2011 to 2025.
- Enanta Pharmaceuticals Inc Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending December 31, 2024 was $3.01M, a 4.3% decline year-over-year.
- Enanta Pharmaceuticals Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2025 was $8.79M, a 24.9% decline from 2024.
- Enanta Pharmaceuticals Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $11.7M, a 489% increase from 2023.
- Enanta Pharmaceuticals Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $1.99M.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)